Placeholder Banner

BIO Statement on CMS' Approval of TennCare Medicaid Waiver

January 11, 2021
Media Contact
Vicky Stinson

Dan Durham, Executive Vice President for Health Policy at the Biotechnology Innovation Organization, released the following statement regarding the recent decision by the Centers for Medicare and Medicaid Services (CMS) to approve the Tennessee Medicaid (TennCare) Section 1115 waiver demonstration:

"We are extremely disappointed that CMS has chosen to approve a waiver demonstration that will put Tennessee Medicaid (TennCare) patients at risk. This dangerous decision will jeopardize access to critical medicines for some of our most vulnerable patients. BIO believes CMS does not have the legal authority to approve the waiver and closed formulary and we will work to protect patient access to the life-saving medicines they need.”

Discover More
Dr. Michelle McMurry-Heath, President and CEO of the Biotechnology Innovation Organization, made the following comments in response to today's violence at the United States Capitol: "Today we watched in horror as angry and unruly mobs attacked…
Court sides with Scientists in a key decision
Washington, DC (November 20, 2020) – Dr. Michelle McMurry-Heath, president and CEO of the Biotechnology Innovation Organization (BIO), issued the following statement after the Trump administration moved forward with its threat to impose…